Legg Mason, Inc. Form 8.3 - Allergan plc (5002G)
20 Novembro 2015 - 12:58PM
UK Regulatory
TIDMPFZ TIDMIRSH
RNS Number : 5002G
Legg Mason, Inc.
20 November 2015
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Legg Mason
(Note 1)
====================== ============
Company dealt in Allergan Plc
====================== ============
Class of relevant IE00BY9D5467
security to which
the dealings being
disclosed relate
(Note 2)
====================== ============
Date of dealing 19/11/15
====================== ============
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
=========================== ================= ===================
Number (%) Number (%)
=========================== ========= ====== =========== ======
7,976,264
(1) Relevant securities 2.02
=========================== ================= ===================
(2) Derivatives (other
than options)
=========================== ================= ===================
(3) Options and agreements
to purchase/sell
=========================== ================= ===================
7,976,264
Total 2.02
=========================== ================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant Long Short
security:
============================ =================== =====================
Number (%) Number (%)
============================ ========= ====== =========== ======
(1) Relevant securities
============================ =================== =====================
(2) Derivatives (other
than options)
============================ =================== =====================
(3) Options and agreements
to purchase/sell
============================ =================== =====================
Total
============================ =================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant Price per
securities unit (Note
5)
=============== =========================== ================
Sale 1,626 $305.70
Purchase 99 $303.98
=============== =========================== ================
(b) Derivatives transactions (other than options transactions)
Product Nature of Number of relevant Price
name, transaction securities per unit
e.g. CFD (Note 6) (Note 7) (Note
5)
========= ============ ================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, Expiry Option
name, selling, of securities price e.g. date money
e.g. purchasing, to which American, paid/received
call varying the option European per unit
option etc. relates etc. (Note
(Note 5)
7)
======= ============ ============== ======== ========== ====== ==============
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call per unit (Note
option 5)
============= =========================== ===================
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of Details Price per
transaction unit
(Note 8) (if applicable)
(Note 5)
============ ============== ====================
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this
should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 20/11/15
============================ ===============
Contact name Shirley Hinton
============================ ===============
Telephone number +1 410 454 5632
============================ ===============
If a connected EFM, n/a
name of offeree/offeror
with which connected
============================ ===============
If a connected EFM, n/a
state nature of connection
(Note 10)
============================ ===============
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEEALFEASKSFFF
(END) Dow Jones Newswires
November 20, 2015 09:58 ET (14:58 GMT)
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024